JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M301232200 on April 3, 2003

J. Biol. Chem., Vol. 278, Issue 28, 25990-25997, July 11, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/28/25990    most recent
M301232200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soelaiman, S.
Right arrow Articles by Tang, W.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soelaiman, S.
Right arrow Articles by Tang, W.-J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structure-based Inhibitor Discovery against Adenylyl Cyclase Toxins from Pathogenic Bacteria That Cause Anthrax and Whooping Cough*

Sandriyana Soelaiman {ddagger} §, Binqing Q. Wei § ¶, Pamela Bergson {ddagger}, Young-Sam Lee ||, Yuequan Shen {ddagger}, Milan Mrksich ||, Brian K. Shoichet ** {ddagger}{ddagger} and Wei-Jen Tang {ddagger} §§

From the {ddagger}Ben-May Institute for Cancer Research, The University of Chicago, Chicago, Illinois 60637, the Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, Illinois 60611, the ||Department of Chemistry, The University of Chicago, Chicago, Illinois 60637, and the **Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143

Edema factor (EF) and CyaA are adenylyl cyclase toxins secreted by pathogenic bacteria that cause anthrax and whooping cough, respectively. Using the structure of the catalytic site of EF, we screened a data base of commercially available, small molecular weight chemicals for those that could specifically inhibit adenylyl cyclase activity of EF. From 24 compounds tested, we have identified one quinazoline compound, ethyl 5-aminopyrazolo[1,5-a]quinazoline-3-carboxylate, that specifically inhibits adenylyl cyclase activity of EF and CyaA with ~20 µM Ki. This compound neither affects the activity of host resident adenylyl cyclases type I, II, and V nor exhibits promiscuous inhibition. The compound is a competitive inhibitor, consistent with the prediction that it binds to the adenine portion of the ATP binding site on EF. EF is activated by the host calcium sensor, calmodulin. Surface plasmon resonance spectroscopic analysis shows that this compound does not affect the binding of calmodulin to EF. This compound is dissimilar from a previously described, non-nucleoside inhibitor of host adenylyl cyclase. It may serve as a lead to design antitoxins to address the role of adenylyl cyclase toxins in bacterial pathogenesis and to fight against anthrax and whooping cough.


Received for publication, February 4, 2003 , and in revised form, March 25, 2003.

* This research was supported by National Institutes of Health Grants GM62548 and GM53459, and an American Heart Association Established Investigator Award (to W.-J. T.), National Institutes of Health Grant 59957 (to B. K. S.), and Defense Advanced Research Projects Agency Grant N00173-01-G010 and National Science Foundation Grant DMR-9808595 (to M. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

{ddagger}{ddagger} To whom correspondence may be addressed: Dept. of Pharmaceutical Chemistry, University of California, Genentech Hall, 600 16th St., San Francisco, CA 94143. E-mail: shoichet{at}cgl.ucsf.edu.

§§ To whom correspondence may be addressed: Ben-May Inst. for Cancer Research, The University of Chicago, 924 East 57th St., Chicago, IL 60637. E-mail: wtang{at}midway.uchicago.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Gottle, S. Dove, P. Steindel, Y. Shen, W.-J. Tang, J. Geduhn, B. Konig, and R. Seifert
Molecular Analysis of the Interaction of Bordetella pertussis Adenylyl Cyclase with Fluorescent Nucleotides
Mol. Pharmacol., September 1, 2007; 72(3): 526 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Hong, R. C. Doebele, M. W. Lingen, L. A. Quilliam, W.-J. Tang, and M. R. Rosner
Anthrax Edema Toxin Inhibits Endothelial Cell Chemotaxis via Epac and Rap1
J. Biol. Chem., July 6, 2007; 282(27): 19781 - 19787.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. M. Firoved, M. Moayeri, J. F. Wiggins, Y. Shen, W.-J. Tang, and S. H. Leppla
Anthrax Edema Toxin Sensitizes DBA/2J Mice to Lethal Toxin
Infect. Immun., May 1, 2007; 75(5): 2120 - 2125.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Sherer, Y. Li, X. Cui, and P. Q. Eichacker
Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 211 - 221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. M. Firoved, G. F. Miller, M. Moayeri, R. Kakkar, Y. Shen, J. F. Wiggins, E. M. McNally, W.-J. Tang, and S. H. Leppla
Bacillus anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice
Am. J. Pathol., November 1, 2005; 167(5): 1309 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
H. Barth, K. Aktories, M. R. Popoff, and B. G. Stiles
Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins
Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 373 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Guo, Y. Shen, N. L. Zhukovskaya, J. Florian, and W.-J. Tang
Structural and Kinetic Analyses of the Interaction of Anthrax Adenylyl Cyclase Toxin with Reaction Products cAMP and Pyrophosphate
J. Biol. Chem., July 9, 2004; 279(28): 29427 - 29435.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gille, G. H. Lushington, T.-C. Mou, M. B. Doughty, R. A. Johnson, and R. Seifert
Differential Inhibition of Adenylyl Cyclase Isoforms and Soluble Guanylyl Cyclase by Purine and Pyrimidine Nucleotides
J. Biol. Chem., May 7, 2004; 279(19): 19955 - 19969.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Shen, N. L. Zhukovskaya, M. I. Zimmer, S. Soelaiman, P. Bergson, C.-R. Wang, C. S. Gibbs, and W.-J. Tang
Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection
PNAS, March 2, 2004; 101(9): 3242 - 3247.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. S. Sarac, J. R. Peinado, S. H. Leppla, and I. Lindberg
Protection against Anthrax Toxemia by Hexa-D-Arginine In Vitro and In Vivo
Infect. Immun., January 1, 2004; 72(1): 602 - 605.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.